“Specifically, what we’re talking about are hot flashes and the accompanying night sweats because those are the most common,” Faubion said. “This is the first-of-its-kind medication, a neurokinin 3 (NK3) receptor antagonist, that tackles moderate to severe hot flashes where they begin — the brain,” she said. Fezolinetant, which goes by the brand name Veozah, “targets the neural activity which causes hot flashes during menopause. Doucefleur/iStockphoto/Getty ImagesAn overactive bladder drug, oxybutynin, also “profoundly dropped hot flashes,” Shufelt said. Studies did show that weight loss reduces hot flashes, as do mindfulness practices such as cognitive behavioral therapy, Shufelt said.

---

Persons: Stephanie Faubion, ”, Chrisandra Shufelt, Shufelt, ” Faubion, “ We’re, “, ” Shufelt, “ You’ve, it’s, I’ve, It’s, Faubion, ‘, I’m Organizations: CNN, Mayo Clinic’s Center, Women’s Health, Women’s Health Research, Mayo Clinic, FDA Locations: Jacksonville , Florida